Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FWSXB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,093
Award facts
- Contract value 100% obligated
- $17,092.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $17,092.53 and is scheduled for completion by September 18, 2025. The contract was executed without a set-aside designation, reflecting open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same municipality.
This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides global pharmaceutical and medical supply support to military healthcare systems and other federal customers, including the Defense Health Agency and U.S. Coast Guard. The IDC enables the company to supply a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor with extensive federal procurement experience, AmerisourceBergen Drug Corp demonstrates capability to fulfill medical supply requirements through its established relationships within the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FWSXB?
SPE2DB25FWSXB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FWSXB worth?
The government has obligated $17,093 on SPE2DB25FWSXB.
Is contract SPE2DB25FWSXB an order under another contract?
Yes. SPE2DB25FWSXB is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB25FWSXB competed?
The extent of competition for SPE2DB25FWSXB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award